Novotech is the leading Asia Pacific centred Biotech Contract Research Organization (CRO) with global execution capabilities.
Novotech is a clinical CRO with labs, phase I facilities, drug development consulting services and FDA regulatory expertise and experience in over 5,000 clinical projects, including Phase I to Phase IV clinical trials and BE studies. Novotech is positioned to serve biotech clients conducting clinical trials in Asia Pacific, the US and Europe.